DNase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DNase, covering 2024-03-19 to 2024-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD) [Phase 2]